Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

10x Genomics, Inc. TXG

Set alert

Price alert · TXG

All alert types
65.47 USD +3.84 +6.23%

As of Nov 3, 2:07 PM ET

Bid
65.36 × 3
Ask
65.46 × 2
62.51 Day range 66.13
12.80 52-week range 102.81
YTD
+301.41%
1 year
+377.88%
Open
63.21
Prev close
61.63
Mkt cap
8.53B
Vol
1.29M
Avg vol
3.43M
EPS
-0.59
P/E
0.00
Div yield
0.00%
More statistics
Low
62.51
High
66.13
Forward P/E
803.83
Beta
2.03
Short ratio
3.09
Inst. own
117.29%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
74.17
200-d avg
40.57
1y target
77.50

5m chart

Chart tools
Interval
1m5m15m30m

Built from the cached five-day intraday bars.

Signals (104)
NameTimeAgo
SMA: BearishNov 3, 12:15 PM1 hour ago
SMA: BullishNov 3, 11:35 AM2 hours ago
SMA: BearishNov 3, 11:30 AM2 hours ago
SMA: BullishNov 3, 11:25 AM2 hours ago
MACD: Sell SignalNov 3, 10:55 AM3 hours ago
SMA: BearishNov 3, 10:50 AM3 hours ago
RSI: OverboughtNov 3, 10:15 AM3 hours ago
SMA: BullishNov 3, 9:30 AM4 hours ago
SMA: BullishNov 3, 9:30 AM4 hours ago
RSI: OverboughtNov 3, 9:30 AM4 hours ago
SMA: BearishNov 2, 3:20 PM22 hours ago
SMA: BullishNov 2, 3:15 PM22 hours ago
SMA: BearishNov 2, 3:10 PM22 hours ago
SMA: BullishNov 2, 2:55 PM23 hours ago
MACD: Buy SignalNov 2, 2:55 PM23 hours ago
MACD: Sell SignalNov 2, 2:35 PM23 hours ago
RSI: OversoldNov 2, 2:30 PM23 hours ago
MACD: Buy SignalNov 2, 2:10 PM23 hours ago
MACD: Sell SignalNov 2, 1:40 PM1 day ago
SMA: BearishNov 2, 1:05 PM1 day ago

Newest 20 of 104.

Analyst view

Consensus: buy

Buy
Price target (mean) 77.50 +18.4% upside
Target (low)
50.00
Target (mean)
77.50
Target (high)
110.00
Ratings (0m) 18 6 buy · 12 hold · 0 sell
  • Strong buy1
  • Buy5
  • Hold12
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 18
  • 1 month ago 19
  • 2 months ago 16

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

TXG analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.02-0.04 – 0.00-0.0228+12.3%147.85M-0.8%2
Next quarter-0.005-0.06 – 0.050.0705-107.1%171.51M+3.3%2
Current year0.03667-0.10 – 0.180.1231-70.2%620.58M-3.5%3
Next year0.076670.01 – 0.170.03667+109.1%683.34M+10.1%3

Upgrades and downgrades

The latest rating changes

TXG analyst upgrades and downgrades
DateFirmActionFromTo
Oct 13, 2026TD CowenMaintainedHoldHold
Oct 13, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Oct 12, 2026Canaccord GenuityMaintainedBuyBuy
Oct 7, 2026BarclaysMaintainedOverweightOverweight
Sep 29, 2026Leerink PartnersMaintainedMarket PerformMarket Perform
Sep 28, 2026Piper SandlerMaintainedNeutralNeutral
Sep 28, 2026Argus ResearchInitiated—Buy
Sep 9, 2026UBSMaintainedNeutralNeutral
Sep 1, 2026RBC CapitalInitiated—Sector Perform
Aug 12, 2026Stephens & Co.MaintainedOverweightOverweight
Aug 10, 2026Piper SandlerMaintainedNeutralNeutral
Aug 10, 2026Canaccord GenuityMaintainedBuyBuy
Aug 7, 2026CitigroupMaintainedNeutralNeutral
Aug 7, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Jul 17, 2026Leerink PartnersMaintainedMarket PerformMarket Perform
Jul 14, 2026Canaccord GenuityMaintainedBuyBuy
Jul 9, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Jul 8, 2026CitigroupMaintainedNeutralNeutral
Jul 1, 2026Piper SandlerMaintainedNeutralNeutral
Jun 24, 2026BarclaysMaintainedOverweightOverweight
May 12, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
May 12, 2026JP MorganMaintainedNeutralNeutral
Apr 20, 2026Canaccord GenuityMaintainedBuyBuy
Apr 20, 2026B of A SecuritiesMaintainedNeutralNeutral
Apr 14, 2026BarclaysMaintainedOverweightOverweight
Apr 7, 2026CitigroupMaintainedNeutralNeutral
Mar 31, 2026William BlairUpgradeMarket PerformOutperform
Mar 2, 2026StifelMaintainedBuyBuy
Feb 20, 2026UBSMaintainedNeutralNeutral
Feb 13, 2026StifelMaintainedBuyBuy